Suppr超能文献

增殖性糖尿病视网膜病变患者玻璃体切除术后需要进行滤过手术的危险因素。

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy.

作者信息

Sakamoto Masashi, Hashimoto Ryuya, Yoshida Izumi, Maeno Takatoshi

机构信息

Department of Ophthalmology, Sakura Medical Center of Toho University, Shimoshizu, Sakura, Japan.

出版信息

Clin Ophthalmol. 2018 Apr 16;12:733-738. doi: 10.2147/OPTH.S158873. eCollection 2018.

Abstract

PURPOSE

We retrospectively reviewed patients with postoperative neovascular glaucoma (NVG) after vitrectomy for proliferative diabetic retinopathy to investigate how variables assessed before, during, and after vitrectomy are associated with the requirement for filtration surgery.

PATIENTS AND METHODS

The subjects in this retrospective, observational, comparative study were 55 consecutive patients (61 eyes) who underwent vitrectomy for proliferative diabetic retinopathy at Toho University Sakura Medical Center between December 2011 and November 2016, were followed up for at least 6 months after surgery, and developed NVG within 2 years after surgery. They comprised 44 men and 11 women of mean age 52.4±9.1 years, who were followed up for a mean 7.1±6.1 months. We collected data on the following 16 variables: sex, age, history of panretinal photocoagulation completed within 3 months before vitrectomy, presence/absence of a lens, obvious iris/angle neovascularization, tractional retinal detachment, diabetic macular edema, vitreous hemorrhage, visual acuity and intraocular pressure before vitrectomy and at the onset of NVG, glycated hemoglobin, fasting blood glucose, estimated glomerular filtration rate, and use of intraoperative gas tamponade.

RESULTS

Logistic regression analysis with the backward elimination method identified preoperative fasting hyperglycemia (=0.08), high intraocular pressure at the onset of NVG (=0.04), and use of gas tamponade during vitrectomy (=0.008) to be significant risk factors for requirement of filtration surgery.

CONCLUSION

Preoperative fasting hyperglycemia, high intraocular pressure at the onset of NVG, and use of gas tamponade during vitrectomy predispose patients to require filtration surgery in the event of postoperative NVG.

摘要

目的

我们回顾性分析了因增生性糖尿病视网膜病变接受玻璃体切除术后发生新生血管性青光眼(NVG)的患者,以研究玻璃体切除术前、术中和术后评估的变量与滤过手术需求之间的关联。

患者与方法

本回顾性、观察性、对比研究的对象为2011年12月至2016年11月期间在东邦大学樱花医疗中心因增生性糖尿病视网膜病变接受玻璃体切除术的55例连续患者(61只眼),术后至少随访6个月,且在术后2年内发生NVG。他们包括44名男性和11名女性,平均年龄52.4±9.1岁,平均随访7.1±6.1个月。我们收集了以下16个变量的数据:性别、年龄、玻璃体切除术前3个月内完成全视网膜光凝的病史、晶状体的有无、明显的虹膜/房角新生血管形成、牵拉性视网膜脱离、糖尿病性黄斑水肿、玻璃体积血、玻璃体切除术前及NVG发作时的视力和眼压、糖化血红蛋白、空腹血糖、估计肾小球滤过率以及术中气体填充的使用情况。

结果

采用向后逐步淘汰法的逻辑回归分析确定,术前空腹血糖升高(=0.08)、NVG发作时眼压升高(=0.04)以及玻璃体切除术中使用气体填充(=0.008)是滤过手术需求的显著危险因素。

结论

术前空腹血糖升高、NVG发作时眼压升高以及玻璃体切除术中使用气体填充使患者在术后发生NVG时倾向于需要滤过手术。

相似文献

1
Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy.
Clin Ophthalmol. 2018 Apr 16;12:733-738. doi: 10.2147/OPTH.S158873. eCollection 2018.
2
Risk factors for neovascular glaucoma after vitrectomy in eyes with proliferative diabetic retinopathy.
Clin Ophthalmol. 2018 Nov 14;12:2323-2329. doi: 10.2147/OPTH.S184959. eCollection 2018.
4
Predictors of visual outcome after pars plana vitrectomy secondary to proliferative diabetic retinopathy.
Rom J Ophthalmol. 2023 Jul-Sep;67(3):283-288. doi: 10.22336/rjo.2023.46.
5
Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.
Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.
6
Frequency and Risk Factors for Neovascular Glaucoma After Vitrectomy in Eyes with Diabetic Retinopathy: An Observational Study.
Diabetes Ther. 2019 Oct;10(5):1801-1809. doi: 10.1007/s13300-019-0644-0. Epub 2019 Jul 18.
8
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.
Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1627-32. doi: 10.1007/s00417-006-0321-7.

引用本文的文献

1
The role of artificial intelligence in analysis of biofluid markers for diagnosis and management of glaucoma: A systematic review.
Eur J Ophthalmol. 2023 Sep;33(5):1816-1833. doi: 10.1177/11206721221140948. Epub 2022 Nov 25.

本文引用的文献

2
Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.
Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.
3
Vitrectomy for complications of proliferative diabetic retinopathy in young adults: clinical features and surgical outcomes.
Graefes Arch Clin Exp Ophthalmol. 2017 May;255(5):863-871. doi: 10.1007/s00417-016-3579-4. Epub 2017 Jan 6.
4
Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole.
PLoS One. 2016 Nov 29;11(11):e0167303. doi: 10.1371/journal.pone.0167303. eCollection 2016.
5
Role of Tamponade in Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage.
Semin Ophthalmol. 2017;32(4):488-491. doi: 10.3109/08820538.2015.1120757. Epub 2016 Apr 29.
6
Long-term intraocular pressure changes after vitrectomy for epiretinal membrane and macular hole.
Graefes Arch Clin Exp Ophthalmol. 2014 Mar;252(3):389-93. doi: 10.1007/s00417-013-2475-4. Epub 2013 Oct 8.
8
Activation of protein kinase C isoforms and its impact on diabetic complications.
Circ Res. 2010 Apr 30;106(8):1319-31. doi: 10.1161/CIRCRESAHA.110.217117.
9
Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008. Epub 2010 Apr 9.
10
Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
J Glaucoma. 2009 Oct-Nov;18(8):632-7. doi: 10.1097/IJG.0b013e3181997211.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验